Impact of molecular response time achievement on survival of chronic phase chronic myelogenous leukemia patients treated by imatinib.
Autor: | Amrita, Putu Niken Ayu1, Bintoro, S. Ugroseno Yudho1 ugrosenoyb2004@yahoo.com |
---|---|
Zdroj: | Drug Invention Today. Jun2020, Vol. 13 Issue 6, p863-867. 5p. 2 Charts, 1 Graph. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |